Skip to main content

Advertisement

Table 2 Cumulative incidences of chronic kidney disease (CKD) between the HBV and non-HBV cohorts in the presence of competing mortality

From: 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan

  HBV cohort, (95 % CI) Non-HBV cohort, (95 % CI) P*
CKD event
At 1 year 0.26 % (0.19–0.35 %) 0.10 % (0.08–0.12 %) <0.001
At 3 years 0.77 % (0.64–0.92 %) 0.33 % (0.29–0.38 %) <0.001
At 5 years 1.35 % (1.17–1.55 %) 0.65 % (0.59–0.72 %) <0.001
At 7 years 2.00 % (1.76–2.26 %) 1.00 % (0.91–1.09 %) <0.001
At 9 year 2.90 % (2.58–3.24 %) 1.48 % (1.37–1.60 %) <0.001
At 11 year 4.30 % (3.85–4.79 %) 2.12 % (1.96–2.29 %) <0.001
At 13 year 6.20 % (5.39–7.08 %) 2.74 % (2.49–3.01 %) <0.001
  1. *Two sample proportion test. Abbreviations: CI confidence interval